Related Experiment Video
Updated: May 20, 2025

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Identification and management of non-obstructive high-risk coronary artery plaque
Craig Balmforth1, Michael McDermott2, Phyo Khaing2
1The University of Edinburgh Centre for Cardiovascular Science, Edinburgh, UK craig.balmforth@ed.ac.uk.
Insights
Advanced imaging identifies high-risk coronary plaques, enabling personalized treatment for heart disease patients. Further studies are needed to integrate these findings into routine clinical practice for better outcomes.
Area of Science:
- Cardiovascular Medicine
- Medical Imaging
- Interventional Cardiology
Background:
- Coronary heart disease (CHD) is a leading global cause of mortality.
- Acute coronary syndromes (ACS) often arise from rupture of high-risk coronary artery plaques.
- Current management strategies for high-risk plaques require further refinement.
Purpose of the Study:
- To explore the role of advanced multimodality imaging in assessing high-risk coronary plaques.
- To evaluate the potential of imaging-based risk stratification for guiding treatment decisions.
- To discuss the implications of precision medicine in managing atherosclerotic disease.
Main Methods:
- Utilizing multimodality imaging techniques for detailed plaque assessment.
- Evaluating plaque burden, high-risk features, activity, and thrombosis.
- Correlating imaging findings with patient risk stratification and potential therapeutic interventions.
Main Results:
- Advanced imaging enables comprehensive assessment of high-risk coronary plaques.
- Imaging facilitates identification of patients who may benefit from intensified therapies or revascularization.
- Potential for improved risk stratification and targeted therapy delivery.
Conclusions:
- Advanced plaque imaging heralds a new era of precision medicine in cardiovascular care.
- Further research and observational studies are crucial for clinical implementation of high-risk plaque metrics.
- Targeting therapies based on advanced imaging can optimize outcomes for high-risk patients.
Abstract:
Despite advances in its understanding and treatment, coronary heart disease remains the leading cause of death worldwide. Acute coronary syndromes most commonly result as a consequence of the rupture of non-flow-limiting, high-risk coronary artery plaques. Advances in multimodality imaging have allowed the detailed assessment of the high-risk plaque including the assessment of plaque burden, high-risk plaque features, plaque activity and thrombosis. This in turn may help identify those patients at greatest risk, and thus benefit from intensification of pharmacotherapies or from local preventative strategies including coronary revascularisation. However, the optimal management of high-risk plaques and the prevention of consequent adverse coronary events have yet to be established. Further development and observational studies are required to determine how best to apply high-risk plaque metrics into clinical practice. Nevertheless, a new era of precision medicine is upon us, with advanced plaque imaging allowing enhanced risk stratification and targeting of the growing armamentarium of atherosclerotic therapies to the highest risk patients.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...